Cheng-Tao Lin
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 7
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 4
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
-
- Cancer Immunotherapy and Biomarkers 4
-
- Pelvic floor disorders treatments 3
-
- Neuroendocrine Tumor Research Advances 2
- Cervical Cancer and HPV Research 2
- Co-authors
- Chyong‐Huey LaiAngel ChaoAlex C. WangCornelia L. TrimbleWarner K. HuhDaejin KimLiangmei HeRonald D. Alvarez
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)American Journal of Obstetrics and Gynecology (1 paper)
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Cheng-Tao Lin
19 papers receiving 453 citations
Peers
Comparison fields: 5 of 54
- Reproductive Medicine 102
- Obstetrics and Gynecology 73
- Immunology 161
- Oncology 168
- Rheumatology 56
Countries citing papers authored by Cheng-Tao Lin
This map shows the geographic impact of Cheng-Tao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Tao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Tao Lin more than expected).
Fields of papers citing papers by Cheng-Tao Lin
This network shows the impact of papers produced by Cheng-Tao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Tao Lin. The network helps show where Cheng-Tao Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng-Tao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2021 | 10 | |
| 3 | 2020 | 30 | |
| 4 | 2019 | 0 | |
| 5 | 2019 | 10 | |
| 6 | 2018 | 15 | |
| 7 | 2017 | 37 | |
| 8 | 2016 | 37 | |
| 9 | 2015 | 3 | |
| 10 | 2014 | 1 | |
| 11 | 2013 | 11 | |
| 12 | 2013 | 0 | |
| 13 | 2012 | 20 | |
| 14 | 2011 | 13 | |
| 15 | 2008 | 6 | |
| 16 | 2007 | 11 | |
| 17 | 2006 | 19 | |
| 18 | 2005 | 10 | |
| 19 | 2004 | 38 | |
| 20 | Defining the priority of using 18F-FDG PET for recurrent cervical cancer. | 2004 | 63 |
About Cheng-Tao Lin
Cheng-Tao Lin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology, having authored 21 papers that have together received 462 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Immune Cell Function and Interaction (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers), Pelvic floor disorders treatments (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Reproductive Medicine (102 citations), Obstetrics and Gynecology (73 citations) and Immunology (161 citations). Cheng-Tao Lin has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Chyong‐Huey Lai, Angel Chao, Alex C. Wang, Cornelia L. Trimble, Warner K. Huh, Daejin Kim, Liangmei He, Ronald D. Alvarez, Archana Monie and Chi‐Mu Chuang. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.